Brown Emery N. 4

What Happened

• Emery N. Brown, a director of Humacyte, Inc. (HUMA), received a grant of 80,000 derivative share awards on June 11, 2026. The reported acquisition price is $0.00, indicating a company award rather than an open-market purchase. No cash changed hands in this filing.

Key Details

• Transaction date: June 11, 2026; Filing date: June 12, 2026 (appears timely).
• Amount: 80,000 derivative securities; reported price per share: $0.00.
• Shares owned after transaction: Not specified in the provided filing.
• Footnote (vesting): First 25% of the option becomes exercisable on June 11, 2027; thereafter 1/48 of the total option vests monthly on the 11th of each month through June 11, 2030.
• Transaction type code: A (grant/award/acquisition of derivative securities).

Context

• This is a grant of share-based compensation to a director (a common, non-sale insider event) and not an open-market purchase or sale. The award vests over time per the schedule above; it does not by itself indicate immediate buying or selling activity.